Verastem Inc (VSTM)
Verastem stock today
Verastem closed at $9.75 on October 30, 2026, up 0.93% on the day. Over the past year it returned +5.6% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $857 million.
| Period | VSTM | S&P 500 (SPY) |
|---|---|---|
| 1 month | +21.1% | -0.9% |
| 3 months | +59.8% | +2.1% |
| Year to date | +26.3% | +11.7% |
| 1 year | +5.6% | +12.4% |
| 3 years | +56.8% | +88.5% |
| 5 years | -68.8% | +76.0% |
Key statistics
- Market value
- $857M
- Price / sales
- 9.8
- 52-week range
- $3.45 to $10.64
- Next report
- Nov 5, 2026
About Verastem
Develops therapeutics for cancer and immune system disorders.
Sector: Health Care
More on Verastem
- Financials: revenue, earnings and segmentsRevenue +209% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $639.76 today
No forecast, no recommendation. This page describes Verastem Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.